News
In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.
Common wrist fracture does not need surgical repair in most cases
By Linda Carroll (Reuters Health) - Most scaphoid waist fractures in adults do not need to be repaired surgically, a new study finds. Outcomes from just over 400 patients with scaphoid waist fractures
Malnutrition tied to worse post-discharge heart failure outcomes
By Lisa Rapaport (Reuters Health) - Hospitalized heart failure patients with insufficient calorie intake may have a poor quality of life and a higher chance of readmission after discharge than their
ARBs may best ACE-inhibitors at preserving cognition in patients with MCI
By Linda Carroll (Reuters Health) - Older adults with mild cognitive impairment (MCI) and high blood pressure had superior cognitive outcomes after a year of treatment with candesartan compared to
Rare TP53 mutation implicated in familial cancers in Ashkenazi Jews, but with low penetrance
By Marilynn Larkin NEW YORK (Reuters Health) - A rare TP53 mutation common in Ashkenazi Jews confers risk of multiple cancers, but while some are early-onset, others may occur later, a genetic
Metformin may benefit overweight women with PCOS undergoing IVF
By Megan Brooks NEW YORK (Reuters Health) - Metformin treatment may be helpful in overweight women (BMI 26 or greater) with polycystic ovary syndrome (PCOS) who are undergoing assisted reproduction,
Dedicated flu clinics may reduce impact of the illness
By Linda Carroll (Reuters Health) - Having clinics designed to treat only the flu might reduce the impact of the disease, a new computer model suggests. By isolating people who have the disease, or
COVID SCIENCE-New clues on virus reproduction mystery; non-COVID vaccines may help
By Nancy Lapid (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by
AI could help track response to anti-VEGF therapy for diabetic macular edema
By Reuters Staff NEW YORK (Reuters Health) - Artificial intelligence (AI) analysis of imaging data could help monitor treatment response in patients with diabetic macular edema (DME) undergoing
Molecular signatures of non-smoking lung cancer in East Asians identified
By Reuters Staff NEW YORK (Reuters Health) - A comprehensive proteogenomic study of non-smoking lung cancer reveals molecular signatures of pathogenesis and progression, researchers in Taiwan report.
Bisphosphonates reduce bone toughness over time
By Will Boggs MD NEW YORK (Reuters Health) - Using bisphosphonates for several years is associated with increasing brittleness and decreasing toughness of bone, according to a new review. "Long-term
Pfizer to make Gilead's COVID-19 treatment remdesivir
By Reuters Staff (Reuters) - Pfizer Inc said on Friday it signed a multiyear agreement to make COVID-19 treatment remdesivir for developer Gilead Sciences Inc, which is under pressure to increase
U.S. surpasses 160,000 coronavirus deaths as school openings near
By Aurora Ellis and Maria Caspani NEW YORK (Reuters) - More than 160,000 people have died from the coronavirus pandemic in the United States, nearly a quarter of the global total, according to a
Alzheimer's drug from Biogen to get speedy U.S. review
By Dania Nadeem and Manojna Maddipatla (Reuters) - The U.S. Food and Drug Administration will conduct an expedited review of an experimental Alzheimer's drug from Biogen Inc and Japan's Eisai Co Ltd,
Mitral valve-in-valve replacements seem safe and successful
By David Douglas NEW YORK (Reuters Health) - Transcatheter mitral valve-in-valve (MViV) replacement of degenerated bioprosthetic valves using the Edwards Lifesciences SAPIEN 3 prosthesis has a high
Fecal microbiota transplantation reduces IBS symptoms
By Will Bogga MD NEW YORK (Reuters Health) - Fecal microbiota transplantation (FMT) reduces symptoms of irritable bowel syndrome (IBS) in some patients, but the benefits wane over time, according to
University of Washington forecasts 300,000 U.S. COVID-19 deaths
By Doina Chiacu and Rich McKay WASHINGTON (Reuters) - Nearly 300,000 Americans could be dead from COVID-19 by Dec. 1, University of Washington health experts forecast on Thursday, although they said
Beta-2 agonists can improve athletes' speed and strength
By Lisa Rapaport (Reuters Health) - Beta-2 agonists can improve speed and strength in athletes without asthma, according to a new study that also suggests this might be true for versions of these
Regular MRI screening suggested for women with familial breast cancer risk
By Marilynn Larkin NEW YORK (Reuters Health) - Women ages 35-60 with a family history of breast cancer can be cost-effectively screened with magnetic resonance imaging (MRI) every 18 months, an
UPDATE 1-Children rapidly deported from the United States strain Guatemalan shelters
(Adds July data on border apprehensions) By Sofia Menchu and Mimi Dwyer GUATEMALA CITY/LOS ANGELES (Reuters) - Hundreds of migrant children rapidly expelled from the United States under a coronavirus
Risks, benefits of IV belimumab in children with SLE consistent with adults
By Marilynn Larkin NEW YORK (Reuters Health) - Intravenous belimumab 10 mg/kg every four weeks was safe and effective in childhood-onset systemic lupus erythematosus (cSLE) in a phase-2
Family wellbeing similar with parents or grandparents heading household
By Lisa Rapaport (Reuters Health) - Grandparents raising children seem to cope as well with parenting duties as parents, even though they're more likely to care for kids with more developmental and
Vitamin D supplements may improve benign paroxysmal positional vertigo
By Lisa Rapaport (Reuters Health) - Some patients with benign paroxysmal positional vertigo (BPPV) may have fewer recurrences if they take vitamin D and calcium supplements, new trial results suggest.
UPDATE 1-U.S. lifts global health coronavirus travel advisory
By David Shepardson and Doina Chiacu WASHINGTON (Reuters) - The U.S. State Department on Thursday lifted a global "Do Not Travel" advisory from March recommending U.S. citizens avoid all international
Fatal pulmonary fibrosis can occur with COVID-19
By Will Boggs MD NEW YORK (Reuters Health) - COVID-19 can result in fatal pulmonary fibrosis, according to a new case report. "We hope that our results will remind clinicians of pulmonary fibrosis as
Coronavirus, other respiratory viruses can cause severe bronchiolitis
By Reuters Staff NEW YORK (Reuters Health) - Coinfections with endemic coronaviruses and other respiratory viruses can cause severe bronchiolitis, according to new findings. Four endemic coronaviruses
Online CPR videos rarely feature women, study finds
By Carolyn Crist NEW YORK (Reuters Health) - About 98% of instructional videos found on online sites about CPR include men or a manikin without a female anatomy, according to a new analysis. Worldwide
Number of incident cancers dropped as pandemic took hold
By Anne Harding NEW YORK (Reuters Health) - The number of newly identified patients with cancer declined significantly after the onset of the pandemic, a new analysis of clinical laboratory data
Global recovery will come faster if COVID vaccine available to all -WHO chief
By Reuters Staff GENEVA (Reuters) - Economic recovery around the world could comes faster if any COVID-19 vaccine is made available to all as a public good, World Health Organization Director General
Antiviral combo shows early promise against HCV in pregnancy
By Scott Baltic NEW YORK (Reuters Health) - The combination of ledipasvir and sofosbuvir appears to be safe and effective in treating pregnant women infected with genotype 1 hepatitis C virus (HCV),
Becton Dickinson on track to produce 1 bln syringes in 12-18 months
By Reuters Staff (Reuters) - Medical device maker Becton Dickinson and Co said on Thursday it would be able to produce 1 billion syringes in the next 12-18 months. The company has received a total
Why the coronavirus is killing so many of Mexico's healthcare workers
By Diego Oré MEXICO CITY (Reuters) - When the coronavirus epidemic began to intensify in Mexico at the end of March, Doctor Jose Garcia said his bosses at a public trauma hospital in Mexico City
Children rapidly deported from the United States strain Guatemalan shelters
By Sofia Menchu and Mimi Dwyer GUATEMALA CITY/LOS ANGELES (Reuters) - Hundreds of migrant children rapidly expelled from the United States under a coronavirus immigration policy are returning to
Women with AF feel worse than men even after ablation
By David Douglas NEW YORK (Reuters Health) - Both before and after catheter ablation to treat atrial fibrillation (AF), women have significantly worse symptom scores and health-related quality of life
Government health experts warn U.S. cities of "trouble ahead"
By Doina Chiacu WASHINGTON (Reuters) - White House health experts are warning of an uptick in the percentage of people testing positive for COVID-19 in U.S. cities including Boston, Chicago and
Trump says coronavirus vaccine possible before Nov. 3
By Reuters Staff WASHINGTON (Reuters) - U.S. President Donald Trump said on Thursday it was possible the United States would have a coronavirus vaccine before the Nov. 3 election, a more optimistic
Patients with gynecologic cancers not at increased risk for severe COVID-19
By Reuters Staff NEW YORK (Reuters Health) - Women with gynecologic cancer do not appear to be at increased risk of being hospitalized with COVID-19 or dying from the infection, according to a study
Worldwide, gout cases and years of disability rising
By Linda Carroll (Reuters Health) - The prevalence of gout and the years lived with disability due to the condition are on the rise worldwide, a new study finds. An analysis of nearly three decades of
EXCLUSIVE-Fauci says regulators promise politics will not guide vaccine timing
By Jeff Mason and Michael Erman WASHINGTON (Reuters) - U.S. regulators have assured scientists that political pressure will not determine when a coronavirus vaccine is approved even as the White House
NY home health workers report personal risks during COVID-19 pandemic
By Lisa Rapaport (Reuters Health) - Home health care workers in New York City report feeling invisible and at personal risk during the COVID-19 pandemic, a small study suggests. Researchers performed
Physicians overlook some preventive services tied to longer life
By Lisa Rapaport (Reuters Health) - Most physicians prioritize which preventive services to discuss with patients based on time constraints and assumptions about which interventions improve quality or
Urgent care membership programs may expand access, not cut costs
By Lisa Rapaport (Reuters Health) - Urgent care center membership programs may provide convenience and expanded access to care to people who are uninsured or underinsured without necessarily saving
Subcutaneous ICDs non-inferior to transvenous devices when pacing isn't needed
By Gene Emery (Reuters Health) - Subcutaneous implantable cardioverter-defibrillators are as effective as conventional transvenous ICDs, according to the first head-to-head prospective comparison,
Risk of mobile phone interference with implanted electronic devices presently low
By Marilynn Larkin NEW YORK (Reuters Health) - The risk of mobile phone-induced electromagnetic inference with cardiovascular implantable electronic devices (CIEDs) was low in an observational study
For relapsing MS, leukemia drug produces one-third improvement over teriflunomide
By Gene Emery (Reuters Health) - In patients with relapsing multiple sclerosis, subcutaneous ofatumumab therapy lowers the 6-month odds of worsening disability by 32% (P=0.01) compared with oral
Cannabidiol has potential to safely treat cannabidiol use disorder
By Marilynn Larkin NEW YORK (Reuters Health) - A phase IIa randomized trial of oral cannabidiol (CBD) for cannabis use disorder showed that 400 mg and 800 mg doses were safe and more effective than
Doctors say Turkish COVID-19 outbreak worse than reported as hospitalisations swell
By Ali Kucukgocmen and Yesim Dikmen ISTANBUL (Reuters) - Doctors in Turkey's coronavirus hotspots say hospitals are filling up with more cases than are reflected in the official nationwide count,
REFILE-Nivolumab plus ipilimumab or pembrolizumab most cost-effective for newly diagnosed advanced melanoma
(Corrects spellig of Dr. Shi's first name in para 3, in story originally published 7/31.) By Marilynn Larkin NEW YORK (Reuters Health) - First-line treatment with nivolumab plus ipilimumab or
REFILE-Nivolumab-ipilimumab combo appear helpful in biliary-tract cancers
(Adds slug, with no change to text.) By David Douglas NEW YORK (Reuters Health) - In patients with advanced biliary-tract cancers, combination immunotherapy with nivolumab and ipilimumab shows
Nivolumab-ipilimumab combo appear helpful in biliary-tract cancers
By David Douglas NEW YORK (Reuters Health) - In patients with advanced biliary-tract cancers, combination immunotherapy with nivolumab and ipilimumab shows promising activity, according to a new study
With no nationwide rule, Amsterdam insists on virus masks
By Toby Sterling AMSTERDAM (Reuters) - The City of Amsterdam on Wednesday began ordering use of face masks in crowded areas such as its "Red Light" prostitution district, in a drive against the
Teladoc bets big on online medicine with $18.5 bln Livongo deal
By Noor Zainab Hussain and Manas Mishra (Reuters) - Teladoc Health Inc has agreed to buy chronic care provider Livongo Health Inc in a deal valuing the company at $18.5 billion, betting on a boom in
Respiratory therapist struggles to catch her own breath after COVID-19
By Ricardo Moraes and Marcelo Rochabrun RIO DE JANEIRO (Reuters) - Ana Carolina Xavier was helping as many as six coronavirus patients a day to slowly recover lung capacity when she began worrying
Hospitalization for IBD should not be delayed in pandemic: experts
By Will Boggs MD NEW YORK (Reuters Health) - Hospitalization of patients with severe or complicated inflammatory bowel disease (IBD) should not be delayed during the COVID-19 pandemic, according to
Spain's Canaries to cover all COVID-related costs for tourists
By Reuters Staff MADRID (Reuters) - All Spanish and foreign tourists visiting the Canary Islands will have any potential coronavirus-related costs covered by the regional government, it said on
Canada signs deals with Pfizer, Moderna for experimental COVID-19 vaccines
By Reuters Staff OTTAWA (Reuters) - Canada has signed separate deals with Pfizer Inc and Moderna Inc to supply millions of doses of their experimental coronavirus vaccines, a top official said on
New York City erects quarantine checkpoints to curb coronavirus
By Maria Caspani NEW YORK (Reuters) - New York City will put up COVID-19 quarantine checkpoints at key entry points to ensure that incoming travelers from 35 states with outbreaks comply with the
Amid quarantine, Ecuador women speak in code to seek protection from domestic violence
By Alexandra Valencia QUITO (Reuters) - Ecuadorean women are using code words to seek help in situations of domestic violence as the country's quarantine is creating conditions for increased abuse of
Pediatric EDs using CT less often; ultrasounds, MRIs on the rise
By Anne Harding NEW YORK (Reuters Health) - Use of advanced imaging in pediatric emergency departments (EDs) increased from 2009-2018 in the U.S., despite a drop in computed tomography (CT), according
New brain death criteria: Coma, brainstem areflexia and apnea
By Will Boggs MD NEW YORK (Reuters Health) - Experts from five professional societies recommend that a clinical examination demonstrating coma, brainstem areflexia and apnea should be used to
Severe COVID-19 in kids rare with variable symptoms and generally good outcomes
By Megan Brooks NEW YORK (Reuters Health) - Critical pediatric COVID-19 disease is a rare entity with heterogeneous clinical presentation and generally good outcomes compared with adults, according to
REFILE-Predicted albumin-creatinine ratio performs well for CKD screening, staging and prognosis
(In para 3, changes CSK to CKD, in story originally published July 13.) By Megan Brooks (Reuters Health) - Researchers with the Chronic Kidney Disease Prognosis Consortium have developed equations to
Brain-computer interface training reduces phantom-limb pain
By Will Boggs MD NEW YORK (Reuters Health) - Brain-computer interface (BCI) to control an image of a phantom hand reduces phantom-limb pain, according to results from a crossover trial. "BCI training
UPDATE 1-Second COVID wave 'highly likely' to hit France this year, scientists say
(Adds Paris considering making masks compulsory, Macron quote) By Reuters Staff PARIS (Reuters) - A second wave of the coronavirus epidemic is highly likely to hit France in the autumn or winter, the
UPDATE 1-UK risks twice-as-big second COVID wave without better testing, study finds
(Adds details, further government comment) By Reuters Staff LONDON (Reuters) - Britain risks a second wave of COVID-19 this winter twice as large as the initial outbreak if it reopens schools
Radiotherapy improves overall survival in metastatic nasopharyngeal carcinoma
By Will Boggs MD NEW YORK (Reuters Health) - Locoregional radiotherapy added to chemotherapy improves overall survival in patients with de novo metastatic nasopharyngeal carcinoma (mNPC), according to
Acetaminophen use linked to false-positive test for chronic granulomatous disease
By Anne Harding NEW YORK (Reuters Health) - Recent acetaminophen use can lead to a false positive result on the dihydrorhodamine (DHR) test, new findings show. "Taking acetaminophen may affect the
Rosuvastatin myotoxicity can emerge after initiating canagliflozin
By Reuters Staff NEW YORK (Reuters Health) - Rosuvastatin myotoxicity can develop after initiation of treatment with canagliflozin, a sodium-glucose cotransporter-2 inhibitor, according to a new case
What to do about interference between maternal pertussis vaccination, infant's DTwP shot
By Reuters Staff NEW YORK (Reuters Health) - Health providers should pay extra attention to infants with signs of pertussis given the potential interaction between maternal vaccination for the disease
Jury out on how best to screen for health-related social needs
By Megan Brooks NEW YORK (Reuters Health) - Screening for health-related social needs, such as housing, food and transportation problems, are increasingly being incorporated into clinical care but the
SPECIAL REPORT-Local governments 'overwhelmed' in race to trace U.S. COVID contacts
By Benjamin Lesser, Dan Levine, Jaimi Dowdell and Andrea Januta (Reuters) - The soaring number of COVID-19 cases in the United States has far outstripped many local health departments' ability to
Prenatal flu vaccine not linked to adverse early childhood outcomes
By Lisa Rapaport (Reuters Health) - In utero exposure to influenza vaccines doesn't appear to contribute to mortality, morbidity or adverse health outcomes in children under five years of age, a
Low-dose antihypertensive combo improves blood pressure control
By Will Boggs MD NEW YORK (Reuters Health) - A low-dose fixed-dose combination of three antihypertensive drugs improves blood pressure control but is associated with greater rates of therapeutic
Sentinel lymph node biopsy holds promise in periocular cancer
By David Douglas NEW YORK (Reuters Health) - Sentinel lymph node biopsy (SLNB) can provide tumor-staging information in patients with malignancies of the conjunctiva and eyelid, but whether SLNB leads
UK risks twice-as-big second COVID wave without better testing, study finds
By Reuters Staff LONDON (Reuters) - Britain faces a second wave of COVID-19 this winter twice as widespread as the initial outbreak if it reopens schools without a more effective test-and-trace system
Taiwan provisionally approves dexamethasone as coronavirus treatment
By Reuters Staff TAIPEI (Reuters) - Taiwan provisionally approved the use of dexamethasone, a cheap and widely-used steroid, to treat the new coronavirus, as the island faces a shortfall of the
Abiomed heart pump gets second FDA emergency use nod for COVID-19 patients
By Reuters Staff (Reuters) - Medical device maker Abiomed Inc said on Tuesday the U.S. Food and Drug Administration granted its left-sided heart pumps emergency use authorization to help patients
WHO says China team interviewed Wuhan scientists over virus origins
By Reuters Staff GENEVA (Reuters) - A World Health Organization team in China to probe the origins of COVID-19 had "extensive discussions" and exchanges with scientists in Wuhan where the outbreak was
FEATURE-Military helps worn-out nurses, sicker patients in California COVID-19 effort
By Sharon Bernstein SACRAMENTO, Calif. (Reuters) - All day long, as Air Force nurse Major Pinky Brewton cares for patients struggling to breathe in California's COVID-19 ravaged San Joaquin Valley,
Germany already dealing with second coronavirus wave - doctors' union
By Reuters Staff BERLIN (Reuters) - Germany is already contending with a second wave of the coronavirus and risks squandering its early success by flouting social distancing rules, the head of the
Second COVID wave 'highly likely' to hit France this year, scientists say
By Reuters Staff PARIS (Reuters) - A second wave of the coronavirus epidemic is "highly likely" to hit France in the autumn or winter, the government's top scientific body warned on Tuesday, as
Curevac names Franz-Werner Haas as CEO
BERLIN, Aug 4 (Reuters) - German biotech firm CureVac on Tuesday appointed acting Chief Executive Officer and Chief Operating Officer (COO) Franz-Werner Haas CEO, with former CEO and co-founder Ingmar
Stress cardiac MRI can help guide decision making for patients with cardiovascular risk
By Marilynn Larkin NEW YORK (Reuters Health) - In symptomatic patients without a history of coronary artery disease (CAD), stress cardiac magnetic resonance (CMR) imaging can reclassify risk, thereby
Multidisciplinary approach bests specialist care for functional GI problems
By Marilynn Larkin NEW YORK (Reuters Health) - For patients with irritable bowel syndrome and other functional gastrointestinal disorders, a multidisciplinary team approach was more effective and less
Some seniors may be left behind as telemedicine becomes more popular
By Linda Carroll (Reuters Health) - Seniors may be left behind in the rush to adopt telemedicine, some because they don't have the equipment or access to the internet, others because disabilities make
Interleukin-1-beta blockade may slow progression of osteoarthritis
By Reuters Staff NEW YORK (Reuters Health) - Interleukin-1-beta is a key player in the osteoarthritis inflammatory process and inhibiting it may help slow the disease process, according to an
UPDATE 1-Eli Lilly tests antibody drug to halt COVID-19 spread in U.S. nursing homes
(Adds details from interview with chief scientific officer) By Michael Erman and Carl O'Donnell (Reuters) - Eli Lilly & Co said on Monday it started a late-stage trial testing whether one of its
Group pelvic floor-muscle training for urinary incontinence noninferior to individual sessions
By Lisa Rappaport (Reuters Health) - Older women with urinary incontinence may experience a similar reduction in episodes with group pelvic floor muscle training compared with one-on-one sessions, a
